The HIV care continuum: No partial credit given

AIDS

Volumn 26, Issue 14, 2012, Pages 1735-1738

  McNairy, Margaret L ^a,b   El Sadr, Wafaa M ^a  

^a Columbia University ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

adherence; HIV; retention

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIVIRAL THERAPY; DISEASE TRANSMISSION; HEALTH CARE; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; SOCIAL ENVIRONMENT; VIRUS LOAD;

ANTI-HIV AGENTS; CONTINUITY OF PATIENT CARE; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HIV SEROPOSITIVITY; HUMANS; MALE; MEDICATION ADHERENCE; NATIONAL HEALTH PROGRAMS; TREATMENT REFUSAL; VIRAL LOAD;

EID: 84866321623     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328355d67b     Document Type: Review

References (28)

1. PEPFAR. The U.S. President's Emergency Plan for AIDS Relief, Seventh Annual Report To Congress. (2011). http://www.pep-far.gov/documents/ organization/166734.pdf. [Accessed on 20 March 2012].
2. WHO, UNAIDS, UNICEF. Global HIV/AIDS Response, epidemic update and health sector progress towards Universal Access, Progress Report. Geneva; 2011. Report No. ISBN 978 92 4 150298 6 (NLM classification: WC 503.6). http://whq libdoc.who.int/publications/2011/9789241502986-eng.pdf. [Accessed on 20 March 2012].
3. UNICEF. Children and AIDS, Fifth Taking Stock Report, (2010). http://www.unicef.org/publications/files/Children-and-AIDS-Fifth-Stocktaking- Report-2010-EN.pdf. [Accessed on 20 March 2012].
4. Cohen SM, Van Handel MM, Branson BM, Blair JM, Hall HI, Hu X, et al. Vital signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep 2011; 60:1618-1623.
5. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011; 52:793-800.
6. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 2011; 8:e1001056.
7. Mugglin CEJ, Wandeler G, Bender N, Gsponer T, Egger M, Keiser O. Linkage, retention, and retention in care [abstract 1143]. In: 19th Conference on Retroviruses and Opportunisitc Infections; 5-8 March 2012. Seattle, Washington.
8. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21-30. (Pubitemid 30432540)
9. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
10. Tripathi A, Gardner LI, Ogbuanu I, Youmans E, Stephens T, Gibson JJ, et al. Predictors of time to enter medical care after a new HIV diagnosis: a statewide population-based study. AIDS Care 2011; 23:1366-1373.
11. Jenness SM, Myers JE, Neaigus A, Lulek J, Navejas M, Raj-Singh S. Delayed entry into HIV medical care after HIV diagnosis: Risk factors and research methods. AIDS Care 2012. [Epub ahead of print].
12. Holtgrave DR. On the epidemiologic and economic importance of the National AIDS strategy for the United States. J Acquir Immune Defic Syndr 2010; 55:139-142.
13. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub Saharan Africa, 2007-2009: systematic review. Trop Med Int Health 2010; 15: 1-15.
14. Barker PM, Mphatswe W, Rollins N. Antiretroviral drugs in the cupboard are not enough: the impact of health systems' performance on mother-to-child transmission of HIV. J Acquir Immune Defic Syndr 2011; 56:e45.
15. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 2009; 4:e5790.
16. Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, et al. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr 2010; 53:405-411.
17. Nachega JB, Morroni C, Zuniga JM, Sherer R, Beyrer C, Solomon S, et al. HIV-related stigma, isolation, discrimination, and ser-ostatus disclosure: a global survey of 2035 HIV-infected adults. J Int Assoc Physicians AIDS Care (Chic) 2012; 11:172-178.
18. Wohl AR, Galvan FH, Myers HF, Garland W, George S, Witt M, et al. Do social support, stress, disclosure and stigma influence retention in HIV care for Latino and African American men who have sex with men and women? AIDS Behav 2011; 15:1098-1110.
19. Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet 2011; 378:1572-1579.
20. Faal M, Naidoo N, Glencross DK, Venter WD, Osih R. Providing immediate CD4 count results at HIV testing improves ART initiation. J Acquir Immune Defic Syndr 2011; 58:e54-e59.
21. Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del Rio C, Strathdee S, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS 2005; 19:423-431. (Pubitemid 40446189)
22. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 2010; 376:1838-1845.
23. Mukund BKC, Murray P. Cell phone short messaging service (SMS) for HIV/AIDS in South Africa: a literature review. Stud Health Technol Inform 2010; 160:530.
24. Emenyonu N, Thirumurthy H, Muyindike W, Mwebesa B, Ragland K, Geng E, et al. Cash transfers to cover clinic transportation costs improve retention in care in a HIV treatment program in rural Uganda [abstract 831]. In: Conference on Retroviruses and Opportunistic Infections; 16-19 February 2010; San Francisco, California.
25. Rawizza HMS, Oyebode T, Sagay S, Adewole I, Okonkwo P, Kanki P,. Evaluation of loss to follow-up within the PMTCT care cascade in a large ART program: Nigeria [abstract 1017]. In: 19th Conference on Retroviruses and Opportunisitic Infections; 5-8 March 2012. Seattle, Washington.
26. Myer LCM, Fox M, Garone D, Wood R, Prozesky H, Ndirangu J, et al. Loss to follow-up and mortality among pregnant and nonpregnant women initiating ART: South Africa [abstract 27]. In: 19th Conference on Retroviruses and Opportunistic Infections; 5-8 March 2011. Seattle, Washington.
27. Wang B, Losina E, Stark R, Munro A, Walensky RP, Wilke M, et al. Loss to follow-up in a community clinic in South Africa: roles of gender, pregnancy and CD4 count. S Afr Med J 2011; 101:253-257.
28. Nolan T, Berwick DM. All-or-none measurement raises the bar on performance. JAMA 2006; 295:1168-1170. (Pubitemid 43352347)